Biology:NCAPH

From HandWiki
Short description: Protein-coding gene in the species Homo sapiens


A representation of the 3D structure of the protein myoglobin showing turquoise α-helices.
Generic protein structure example

Condensin complex subunit 2 also known as chromosome-associated protein H (CAP-H) or non-SMC condensin I complex subunit H (NCAPH) is a protein that in humans is encoded by the NCAPH gene.[1][2] CAP-H is a subunit of condensin I, a large protein complex involved in chromosome condensation. Abnormal expression of NCAPH may be linked to various types of carcinogenesis as a prognostic indicator.[3]

Function

CAP-H is a member of the barr protein family and a regulatory subunit of the condensin complex. This complex is required for the conversion of interphase chromatin into condensed chromosomes.[3] CAP-H is associated with mitotic chromosomes, except during the early phase of chromosome condensation. During interphase, the protein has a distinct punctate nucleolar localization.[2]

Structure and interactions

Condensin protein complex.
NCAPH, or CAP-H Joining the terminal ends of the SMC-2 and SMC-4 heterodimer to create the condensin holocomplex.

As one of the main subunits in the highly conserved SMC condensin I complex in eukaryotes, NCAPH associates with NCAPG, NCAPD2, and the N and C termini of the SMC-4 and SMC-2 proteins. NCAPH creates a bridge between the head groups of the SMC proteins and functions as a kleisin protein.[3][4][5]

The interaction between NCAPH and the globular ATPase head binding sites of the C terminus and N terminus of the SMC heterodimer allows condensin to have dynamic properties. The C terminus end of NCAPH assumes a winged-helix conformation, which then associates with either head group of the SMC protein. At the opposite end of the kleisin protein, the N terminus associates with proximal coiled coil of the other SMC protein, and creates a helical bundle.[4] This attribute enables the condensin complex to have open and closed conformations in order to associate with chromatin and aid in proper folding of DNA in the condensation process.[5][6]

Studies suggest that the sub-complex formed between NCAPH and NCAPG is critical for interactions with single-stranded DNA and double-stranded DNA to assist mitotic chromosome assembly in eukaryotes.[5]

Clinical significance

NCAPH may be used as a prognostic indicator of carcinogenesis in humans, as the abnormal over-expression of NCAPH is observed in many cancer types.[7]

Studies show that, in prostate cancer,[8] nasopharyngeal carcinoma,[9] hepatocellular carcinoma,[10] and breast cancers,[11] NCAPH is commonly over-expressed, and may be used as a biomarker for various cancer types and a viable prognostic factor for identification and potential drug targeting.[8]

In colon cancer, NCAPH is shown to be higher expressed in cancerous cells compared to non-cancerous epithelial cells. supplementally, when NCAPH is depleted, studies show a decrease in colon cancer cell proliferation.[7][12]  Studies show that high expression of NCAPH in colon cancer and non-small cell lung cancer patients had an increased survival rate than those with a lower expression of NCAPH.[12]

References

  1. "Localization of BRRN1, the human homologue of Drosophila barr, to 2q11.2". Genomics 46 (2): 311–313. December 1997. doi:10.1006/geno.1997.5021. PMID 9417923. 
  2. 2.0 2.1 "Entrez Gene: NCAPH non-SMC condensin I complex, subunit H". https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=23397. 
  3. 3.0 3.1 3.2 "Overexpression of NCAPH is upregulated and predicts a poor prognosis in prostate cancer". Oncology Letters 17 (6): 5768–5776. June 2019. doi:10.3892/ol.2019.10260. PMID 31186803. 
  4. 4.0 4.1 "Kite Proteins: a Superfamily of SMC/Kleisin Partners Conserved Across Bacteria, Archaea, and Eukaryotes". Structure 23 (12): 2183–2190. December 2015. doi:10.1016/j.str.2015.10.004. PMID 26585514. 
  5. 5.0 5.1 5.2 "Structural basis of HEAT-kleisin interactions in the human condensin I subcomplex". EMBO Reports 20 (5). May 2019. doi:10.15252/embr.201847183. PMID 30858338. 
  6. "Kite Proteins: a Superfamily of SMC/Kleisin Partners Conserved Across Bacteria, Archaea, and Eukaryotes". Structure 23 (12): 2183–2190. December 2015. doi:10.1016/j.str.2015.10.004. PMID 26585514. 
  7. 7.0 7.1 "NCAPH plays important roles in human colon cancer". Cell Death & Disease 8 (3): e2680. March 2017. doi:10.1038/cddis.2017.88. PMID 28300828. 
  8. 8.0 8.1 "Overexpression of NCAPH is upregulated and predicts a poor prognosis in prostate cancer". Oncology Letters 17 (6): 5768–5776. June 2019. doi:10.3892/ol.2019.10260. PMID 31186803. 
  9. "Aberrant expression of β-catenin and E-cadherin is correlated with poor prognosis of nasopharyngeal cancer". Human Pathology 44 (7): 1357–1364. July 2013. doi:10.1016/j.humpath.2012.10.025. PMID 23375645. 
  10. "Non-SMC condensin I complex subunit H enhances proliferation, migration, and invasion of hepatocellular carcinoma". Molecular Carcinogenesis 58 (12): 2266–2275. December 2019. doi:10.1002/mc.23114. PMID 31523845. 
  11. "Identification of NCAPH as a biomarker for prognosis of breast cancer". Molecular Biology Reports 47 (10): 7831–7842. October 2020. doi:10.1007/s11033-020-05859-9. PMID 33009967. 
  12. 12.0 12.1 "NCAPH is negatively associated with Mcl‑1 in non‑small cell lung cancer". Molecular Medicine Reports 22 (4): 2916–2924. October 2020. doi:10.3892/mmr.2020.11359. PMID 32945371. 

Further reading